Uplisting

Definition

Uplisting refers to a publicly traded company graduating from over-the-counter (OTC) markets onto a major U.S. exchange — typically the NYSE or NASDAQ. For cannabis companies, the meaningful split is plant-touching (cultivation, processing, retail) vs. ancillary (technology, real estate, services). U.S. plant-touching operators — including every U.S. MSO — cannot list on NYSE/NASDAQ today because federal illegality violates the exchanges' listing standards. They trade on OTC Markets (often the Pink Sheets), with their Canadian holding entities listed on the CSE. Ancillary cannabis companies and Canadian LPs (which operate under federal Canadian legality) can and do uplist.

Also known as: Major exchange listing, NYSE/NASDAQ listing

Why It Matters for Investors

Uplisting eligibility is the single sharpest catalyst-driven valuation lever in cannabis. Major-exchange listing would unlock index fund inclusion, options chains, institutional ownership floors, and dramatically tighter bid-ask spreads. Most MSOs trade at 30–50% discounts to comparable LPs partially due to OTC liquidity constraints alone.

Examples in Practice

• Tilray (TLRY) is NASDAQ-listed because it is a Canadian LP, not a U.S. operator.
• Curaleaf (CURLF), the largest MSO by revenue, trades OTC because of its U.S. plant-touching operations.